Filana Therapeutics FLNA
NASDAQ FLNA
$0.96 +0.02 (+1.96%)
At close: Aug 21, 2026 · 4:00 PM EDT

Filana Therapeutics (FLNA) Prepaid Assets (2010 - 2026)

Filana Therapeutics (FLNA) posted quarterly Prepaid Assets of $1.0 million for Q2 2026, down 57.3% year-over-year from $2.4 million in Q2 2025, and down 25.09% quarter-over-quarter from $1.4 million in Q1 2026.

Filana Therapeutics (FLNA) Prepaid Assets (2010 - 2026) Analysis & Trends

Filana Therapeutics' Prepaid Assets history runs 17 years deep, the most recent figure standing at $1.0 million for Q2 2026.

  • In Q2 2026, Prepaid Assets fell 57.3% year-over-year to $1.0 million; the TTM figure through Jun 2026 stood at $1.0 million (down 57.3% YoY), while the FY2025 annual figure was $2.2 million, down 72.27% from the prior year.
  • Prepaid Assets for Q2 2026 stood at $1.0 million, down from $1.4 million in the prior quarter.
  • The five-year high for Prepaid Assets was $14.8 million in Q2 2024, with the low at $1.0 million in Q2 2026.
  • The 5-year median for Prepaid Assets is $7.9 million (2023), against an average of $7.2 million.
  • The sharpest annual moves came in 2022 and 2025: Prepaid Assets surged 694.6% in 2022, then tumbled 83.55% in 2025.
  • Filana Therapeutics' Prepaid Assets stood at $10.2 million in 2022, then slipped by 16.79% to $8.5 million in 2023, then fell by 6.34% to $8.0 million in 2024, then tumbled by 72.27% to $2.2 million in 2025, then slumped by 52.79% to $1.0 million in 2026.
  • Business Quant data shows FLNA's Prepaid Assets at $1.0 million in Q2 2026, $1.4 million in Q1 2026, and $2.2 million in Q4 2025.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Vertex Pharmaceuticals 139.13 Bn 131.28 Bn 2.84 Bn
2 Regeneron Pharmaceuticals 85.77 Bn 77.77 Bn 3.93 Bn
3 Argenx Se 64.64 Bn 59.46 Bn 1.37 Bn
4 Moderna 58.29 Bn 53.16 Bn 52.00 Mn
5 BeOne Medicines 41.92 Bn 36.82 Bn 1.53 Bn
6 Alnylam Pharmaceuticals 31.58 Bn 28.28 Bn 992.69 Mn
7 BioNTech SE 28.12 Bn 9.73 Bn 668.28 Mn
8 Insmed 27.39 Bn 26.22 Bn 358.27 Mn
9 Royalty Pharma 27.27 Bn 26.43 Bn -
10 Filana Therapeutics 46.00 Mn 46.00 Mn -

Historic Data

Download Data
DateValue
Jun 30, 2026 1.04 Mn
Mar 31, 2026 1.39 Mn
Dec 31, 2025 2.21 Mn
Sep 30, 2025 2.83 Mn
Jun 30, 2025 2.44 Mn
Mar 31, 2025 2.82 Mn
Dec 31, 2024 7.96 Mn
Sep 30, 2024 13.57 Mn
Jun 30, 2024 14.83 Mn
Mar 31, 2024 9.83 Mn
Dec 31, 2023 8.50 Mn
Sep 30, 2023 7.83 Mn
Jun 30, 2023 8.50 Mn
Mar 31, 2023 7.53 Mn
Dec 31, 2022 10.21 Mn
Sep 30, 2022 8.61 Mn
Jun 30, 2022 6.97 Mn
Mar 31, 2022 12.51 Mn
Dec 31, 2021 11.05 Mn
Sep 30, 2021 10.39 Mn